Novartis AG (NVSN) — Free Cash Flow Generation Index
Novartis AG (NVSN) has a Free Cash Flow Generation Index of 0.78x as of March 2026. Free cash flow of MX$2.87 Billion represents 1% of operating cash flow (MX$3.68 Billion). Read Novartis AG (NVSN) total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Novartis AG Free Cash Flow Generation Index (2014–2025)
Historical FCF Generation Index trend for Novartis AG across 12 annual periods. Explore reinvestment intensity of Novartis AG to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Novartis AG (2014–2025)
Year-by-year Free Cash Flow Generation Index for Novartis AG. For the full company profile including market capitalisation, see Novartis AG market capitalisation.
| Year | FCG Index | Free Cash Flow (MXN) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.80x | MX$15.24 Billion | MX$19.14 Billion | MX$3.90 Billion | ▲ +1.6% |
| 2024 | 0.78x | MX$13.80 Billion | MX$17.62 Billion | MX$3.81 Billion | ▼ -4.3% |
| 2023 | 0.82x | MX$13.12 Billion | MX$16.02 Billion | MX$2.90 Billion | ▲ +0.8% |
| 2022 | 0.81x | MX$11.56 Billion | MX$14.24 Billion | MX$1.20 Billion | ▲ +1.2% |
| 2021 | 0.80x | MX$12.10 Billion | MX$15.07 Billion | MX$1.38 Billion | ▼ -1.0% |
| 2020 | 0.81x | MX$11.06 Billion | MX$13.65 Billion | MX$1.27 Billion | ▼ -2.8% |
| 2019 | 0.83x | MX$11.37 Billion | MX$13.62 Billion | MX$1.38 Billion | ▲ +9.1% |
| 2018 | 0.76x | MX$10.92 Billion | MX$14.27 Billion | MX$1.25 Billion | ▼ -2.2% |
| 2017 | 0.78x | MX$9.88 Billion | MX$12.62 Billion | MX$1.32 Billion | ▼ -37.5% |
| 2016 | 1.25x | MX$14.35 Billion | MX$11.47 Billion | MX$2.88 Billion | ▲ +4.3% |
| 2015 | 1.20x | MX$14.26 Billion | MX$11.90 Billion | MX$2.37 Billion | ▲ +0.9% |
| 2014 | 1.19x | MX$16.52 Billion | MX$13.90 Billion | MX$2.62 Billion | — |